You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1626 to 1650 of about 5897
Next 25
09/01/2016
Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.
08/31/2016
Musella Foundation Copay Assistance Program reopens!
Immunotherapy, Vaccines Offer Promise in Glioblastoma, But Data is Still Preliminary
Kadmon launches mid-stage study of lead oncology candidate in brain cancer
08/25/2016
NY Islanders fundraiser for Brain Tumor Research!
08/24/2016
Update published for "Treatment Options For Glioblastoma and other Glioma"
08/23/2016
Curcumin Changes the Polarity of Tumor-Associated Microglia and Eliminates Glioblastoma.
08/18/2016
Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.
Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
08/16/2016
Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13
08/13/2016
MANY CANCER PATIENTS MUST FACE BANKRUPTCY—OR DIE
08/10/2016
Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.
Call for chefs to enter Flo’s Chili Cook-Off
07/26/2016
NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma
International Study Finds Effective, Less Toxic Way to Treat Brain Tumors
Musella Foundation awards $149,992 in 3 brain tumor research grants.
Musella Foundation Co-payment Assistance Program is now closed to new patients
07/25/2016
NCCN updated CNS cancer treatment guidelines to include Optune
Musella Foundation Co-payment Assistance Program about to close to new patients
07/23/2016
DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology (EANO) Annual Meeting in October 2016
Local Biotech Company Develops Therapy to Treat Brain Cancer for Extended Survival
07/21/2016
PD-1 blockade enhances the vaccination induced immune response in glioma
07/16/2016
Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21st century cancer therapeutics